VIGENE CAPITAL
Vigene Capital is an independent investment banking firm serving worldwide companies that participate in the China market. It concentrates our energy on corporate financing, M&A, restructuring, strategic advisory services for technology companies, fast-growing enterprises, and other vital companies with core competence or distinctive business models across industry sectors.
VIGENE CAPITAL
Founded:
2012-01-01
Status:
Closed
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving
Similar Organizations
EXS Capital
EXS Capital is an independent investment firm.
Overture Advisors
Overture Advisors is an independent investment banking service provider company.
RB Capital Partners
RB Capital Partners is an independent investment consulting firm focusing on companies.
More informations about "Vigene Capital"
Vigene Is Acquired By Charles River - Baird
Vigene Biosciences, Inc. (“Vigene” or the “Company”), a portfolio company of Signet Healthcare Partners (“Signet”), has signed a definitive agreement to be acquired by Charles River Laboratories International, Inc. (“Charles River”) …See details»
Vigene Capital - Crunchbase
Companies like Vigene Capital include RB Capital Partners, EXS Capital, and Overture Advisors. RB Capital Partners London , England , United Kingdom 1-10 employeesSee details»
Charles River Signals Gene Therapy Expansion with …
May 18, 2021 The Vigene purchase continues a series of acquisitions for Charles River in recent years that has seen it buy Cognate, contract research organization (CRO) Retrogenix for $48 million in March ...See details»
Vigene Biosciences Is Now Part of Charles River
In June 2021, Charles River acquired Vigene Biosciences, a trusted leader in contract development and manufacturing (CDMO) solutions for cell and gene therapy. ... efficient production timelines through our integrated global network …See details»
Vigene Biosciences Acquired by Charles River …
Jun 29, 2021 Based in Rockville, Maryland, Vigene Biosciences is a premier, gene therapy contract development and manufacturing organization (CDMO), providing viral vector-based gene delivery solutions. Vigene’s primary area of …See details»
Vigene Capital - Tech Stack, Apps, Patents & Trademarks
Organization. Vigene Capital . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 1. About. Vigene Capital is actively …See details»
Charles River Completes the Acquisition of Vigene …
Jun 29, 2021 The acquisition of Vigene Biosciences, a leading contract development and manufacturing organization (CDMO) providing viral vector-based gene delivery solutions, strengthens our ability to support our clients …See details»
Charles River Laboratories Completes Acquisition of Vigene
Jun 29, 2021 Based in Rockville, Maryland, Vigene Biosciences is a premier, gene therapy contract development and manufacturing organization (CDMO), providing viral vector-based …See details»
Charles River To Acquire Vigene Biosciences For $292.5 Mln In
May 17, 2021 The addition of Vigene Biosciences' extensive gene therapy expertise will enable Charles River to expand its comprehensive cell and gene therapy portfolio to span each of the …See details»
Charles River to Acquire Vigene Biosciences for up to $350 million
May 17, 2021 Charles River plans to enhance its gene therapy capabilities through the acquisition of Vigene Biosciences. Charles River announced on May 17, 2021 that it has …See details»
Charles River Laboratories Completes Acquisition of Rockville’s …
Jun 29, 2021 Based in Rockville, Maryland, Vigene Biosciences is a premier, gene therapy contract development and manufacturing organization (CDMO), providing viral vector-based …See details»
Charles River Laboratories Completes Acquisition of Vigene …
Jun 29, 2021 Based in Rockville, Maryland, Vigene Biosciences is a premier, gene therapy contract development and manufacturing organization (CDMO), providing viral vector-based …See details»
Charles River Snags Gene Therapy CDMO Vigene Biosciences
Jul 2, 2021 Based in Rockville, Maryland, Vigene Biosciences is a premier, gene therapy contract development and manufacturing organization (CDMO), providing viral vector-based …See details»
Vigene Biosciences Secures Institutional Investment in New Round …
Apr 29, 2019 The growth capital will be used to support Vigene's expansion into a new facility to support the growing demand for viral vector and plasmid production in the rapidly expanding …See details»
Vigene Biosciences - Raised $10.5M Funding from 3 investors
Nov 1, 2024 Vigene Biosciences has raised a total funding of $10.5M over 2 rounds from 3 investors. Investors include Signet Healthcare Partners, CYwP Funds and 1 other. Their latest …See details»
Vigene Biosciences Secures Institutional Investment in New Round …
Apr 29, 2019 The growth capital will be used to support Vigene's expansion into a new facility to support the growing demand for viral vector and plasmid production in the rapidly expanding …See details»
Vigene Biosciences Company Profile 2024: Valuation, Investors ...
BroadOak Capital Partners, Current Yield with Participation Fund, and Signet Healthcare Partners have invested in Vigene Biosciences. Who are Vigene Biosciences’s competitors? Yposkesi , …See details»
Vigene Biosciences Revenue, Growth & Competitor Profile
Nov 25, 2024 The Premium Vigene Biosciences Company Report contains critical information including: Revenue from previous years (2020 to present) Growth rate Estimated financials …See details»
Our History – A Legacy of Innovation and Integrity - Capital Group
Dec 31, 2023 Discover the storied history of Capital Group, from its founding in 1931 to becoming a global leader in investment management. Learn how our commitment to integrity, …See details»
Vigene Biosciences - Crunchbase Company Profile & Funding
Vigene Biosciences may be growing as indicated by the opening of a new gene therapy contract manufacturing facility, which is a sign of expansion to support its rapid growth. The company is …See details»